High level of carbapenem resistance and transmission ability of bla IMP-26 in multidrug-resistant Enterobacter xiangfangensis isolates from China
mSystems · 2025
DOI: 10.1128/msystems.00578-25 ↗Kurz gefasst
Fachartikel in der Zeitschrift mSystems, 2025. Verfasst von Qizhao Gao und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China. Hauptthemen laut MEDLINE: beta-Lactamases, Drug Resistance, Multiple, Bacterial, Carbapenems, Enterobacteriaceae Infections. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Key Research and Development Project of Jiangsu Provincial Scinence and Technology Department, the Project of MOE Key Laboratory of Geriatric Diseases and Immunology of Soochow University.
Abstract (Originalsprache)
The emergence of metallo-beta-lactamase gene variants, such as bla IMP-26 , has posed a significant challenge to bacterial infection treatment, drawing considerable attention in public health. This study aims to investigate the resistance mechanism of bla IMP-26 -carrying clinical Enterobacter xiangfangensis in China. bla IMP-26 -harboring carbapenem-resistant Enterobacteriaceae (CRE) isolates were collected from a multicenter study across China. The bla IMP-26 was identified by polymerase chain reaction (PCR). Multi-locus sequence typing (MLST) and phylogenetic analysis were conducted to investigate the genetic evolutionary characterization of Enterobacteriaceae carrying bla IMP-26 . The genomic contexts of these strains were explored by whole genome sequencing, while conjugation and plasmid stability assays were conducted to assess the transferability and maintenance of the resistance plasmids. Furthermore, the antibiotic susceptibility of IMP-26 to β-lactams was evaluated through antimicrobial susceptibility testing, enzyme kinetic analysis, and molecular docking. Five bla IMP-26 -carrying strains were collected, and all were multidrug-resistant Enterobacter xiangfangensis. bla IMP-26 was located either on IncHI2/2A or the novel Inc pKPC-CAV1321 plasmid, both exhibiting high and stable self-transfer frequency. In addition, bla IMP-26 was identified within a novel class 1 integron In437, or the classical integron In837. Antimicrobial susceptibility testing and enzyme kinetic assay further showed that IMP-26 could mediate high levels of resistance to common carbapenem and cephalosporin antibiotics. This study characterized the genomic and clinical characteristics of bla IMP-26 -carrying clinical Enterobacter xiangfangensis in China. The high carbapenem resistance and transmission capacity of bla IMP-26 highlight the need for enhanced surveillance and preventive measures to contain the spread of bla IMP-26 . IMPORTANCE Our research has led to the documentation of a novel IncpKPC-CAV1321 plasmid and the discovery of a novel integron In437, both carrying the bla IMP-26 gene. A comprehensive analysis of the carbapenem resistance levels and enzymatic kinetics exhibited by IMP-26 revealed that IMP-26 could mediate high levels of resistance to common carbapenem and cephalosporin antibiotics. Our findings underscore the critical need for enhanced surveillance and preventive measures to curtail the dissemination of bla IMP-26 .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Laboratory, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.
- Department of Clinical Laboratory, Zhenjiang First People's Hospital, Zhenjiang, Jiangsu, China.
- Department of Blood Transfusion, Anhui Chest Hospital, Hefei, China.
- Center of Medical Laboratory, General Hospital of Ningxia Medical University, Yinchuan, China.
- Department of Laboratory Medicine, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
- Department of Laboratory Medicine and Sichuan Provincial Key Laboratory for Human Disease Gene Study, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.
ORCID-Profile: Qizhao Gao, Hong Du
Förderung
- the Key Research and Development Project of Jiangsu Provincial Scinence and Technology Department
- the Project of MOE Key Laboratory of Geriatric Diseases and Immunology of Soochow University
Zitieren
APA
Gao, Q., Wen, Y., Zhai, Y., Qian, F., Tian, X., Zhu, Z., Zhu, J., Jia, W., Tao, J., Huang, B., Yu, H., Xie, X., Chen, L., & Du, H. (2025). High level of carbapenem resistance and transmission ability of bla IMP-26 in multidrug-resistant Enterobacter xiangfangensis isolates from China. mSystems. https://doi.org/10.1128/msystems.00578-25
Vancouver
Gao Q, Wen Y, Zhai Y, Qian F, Tian X, Zhu Z, et al. High level of carbapenem resistance and transmission ability of bla IMP-26 in multidrug-resistant Enterobacter xiangfangensis isolates from China. mSystems. 2025. doi:10.1128/msystems.00578-25
BibTeX
@article{Gao2025,
author = {Gao, Qizhao and Wen, Yicheng and Zhai, Yaxuan and Qian, Feinan and Tian, Xiangxiang and Zhu, Zhichen and Zhu, Jie and Jia, Wei and Tao, Jia and Huang, Bin and Yu, Hua and Xie, Xiaofang and Chen, Liang and Du, Hong},
title = {High level of carbapenem resistance and transmission ability of bla IMP-26 in multidrug-resistant Enterobacter xiangfangensis isolates from China},
journal = {mSystems},
year = {2025},
doi = {10.1128/msystems.00578-25}
}
EUVIMED